The upregulation of miR-770-5p, by its action as an anti-oncogene, promotes cisplatin sensitivity in ovarian cancers through downregulating the expression of NEAT1 (Zhu M. et al., 2020). The gene discussed is NEAT1; the disease is ovarian carcinoma.